Agilent Acquires Luxcel Biosciences

Agilent stock is up heading into the announcement that the company acquired Luxcel Biosciences. I think the stock has run up too far to be a good entry right now.

Agilent stock

Agilent Technologies has acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based from vitro cell assay kits. This acquisition expands Agilent's cell evaluation portfolio with the inclusion of easy-to-use assay kits which are compatible with industry standard plate-readers.

Author: Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on unless specifically stated in the article. Owner of Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.

Sofi AI Market Sentiment Gauge

Sofi AI Market Sentiment Gauge

Market is neither overbought or oversold.